VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 157 filers reported holding VIKING THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,116,318 | -35.4% | 39,923 | -0.0% | 0.02% | -32.4% |
Q1 2024 | $3,274,342 | +1004.4% | 39,931 | +150.6% | 0.04% | +1133.3% |
Q4 2023 | $296,476 | +68.1% | 15,931 | 0.0% | 0.00% | +50.0% |
Q3 2023 | $176,356 | -31.7% | 15,931 | 0.0% | 0.00% | -33.3% |
Q2 2023 | $258,242 | -2.6% | 15,931 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $265,251 | +77.1% | 15,931 | 0.0% | 0.00% | +50.0% |
Q4 2022 | $149,751 | +248.3% | 15,931 | 0.0% | 0.00% | +100.0% |
Q3 2022 | $43,000 | -12.2% | 15,931 | -5.9% | 0.00% | 0.0% |
Q2 2022 | $49,000 | -9.3% | 16,931 | -6.4% | 0.00% | – |
Q1 2022 | $54,000 | -99.8% | 18,081 | -99.7% | 0.00% | -100.0% |
Q4 2021 | $32,480,000 | -35.3% | 7,060,803 | -11.7% | 0.26% | -33.8% |
Q3 2021 | $50,197,000 | +9.2% | 7,993,211 | +4.2% | 0.39% | +13.6% |
Q2 2021 | $45,947,000 | -5.0% | 7,670,552 | +0.3% | 0.35% | -4.4% |
Q1 2021 | $48,379,000 | +1.0% | 7,648,852 | -10.1% | 0.36% | -2.4% |
Q4 2020 | $47,899,000 | +3.0% | 8,507,790 | +6.5% | 0.37% | -16.3% |
Q3 2020 | $46,494,000 | -23.8% | 7,988,635 | -5.6% | 0.44% | -29.7% |
Q2 2020 | $61,017,000 | +47.7% | 8,462,833 | -4.1% | 0.63% | +16.2% |
Q1 2020 | $41,299,000 | -41.6% | 8,824,526 | +0.1% | 0.54% | -13.8% |
Q4 2019 | $70,685,000 | +26.3% | 8,813,578 | +8.4% | 0.63% | +12.7% |
Q3 2019 | $55,945,000 | -1.6% | 8,131,528 | +18.7% | 0.56% | +2.0% |
Q2 2019 | $56,864,000 | +27.1% | 6,851,093 | +52.3% | 0.55% | +29.9% |
Q1 2019 | $44,722,000 | +53.9% | 4,499,204 | +18.5% | 0.42% | +38.0% |
Q4 2018 | $29,050,000 | -41.9% | 3,797,336 | +32.3% | 0.30% | -27.2% |
Q3 2018 | $50,014,000 | +205.7% | 2,871,087 | +66.5% | 0.42% | +179.3% |
Q2 2018 | $16,361,000 | +129.9% | 1,723,982 | +5.8% | 0.15% | +111.3% |
Q1 2018 | $7,118,000 | – | 1,628,751 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |